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The investigation of unexplained syncope remains a challenging clinical problem. In the present study we sought to evaluate the
diagnostic value of a standardized work-up focusing on non invasive tests in patients with unexplained syncope referred to a syncope
clinic, and whether certain combinations of clinical parameters are characteristic of rhythmic and reflex causes of syncope.
Methods and results: 317 consecutive patients underwent a standardized work-up including a 12-lead ECG, physical examination, detailed
history with screening for syncope-related symptoms using a structured questionnaire followed by carotid sinus massage (CSM), and
head-up tilt test. Invasive testings including an electrophysiological study and implantation of a loop recorder were only performed in
those with structural heart disease or traumatic syncope. Our work-up identified an etiology in 81% of the patients. Importantly, three
quarters of the causes were established non invasively combining head-up tilt test, CSM and hyperventilation testing. Invasive tests
yielded an additional 7% of diagnoses. Logistic analysis identified age and number of significant prodromes as the only predictive factors
of rhythmic syncope. The same two factors, in addition to the duration of the ECG P-wave, were also predictive of vasovagal and
psychogenic syncope. These factors, optimally combined in predictive models, showed a high negative and a modest positive predictive
value.
Conclusion: A standardized work-up focusing on non invasive tests allows to establish more than three quarters of syncope causes. Predictive
models based on simple clinical parameters may help to distinguish between rhythmic and other causes of syncope.
© 2007 Elsevier Ireland Ltd. All rights reserved.Keywords: Syncope; Diagnostic yield; Diagnosis; Syncope unit1. Introduction
Syncope, a common and challenging symptom, remains
unexplained in up to 60% of the cases [1–6]. Some in-
vestigators have recently shown the superiority of simple
investigation strategies over usual practice in patients with
syncope addressed to emergency departments [1,6–8]. The
development of syncope clinics has dramatically changed
the evaluation of syncope by re-orienting patients toward
functional investigations; however, little is known about the⁎ Corresponding author. Tel.: +41 21 3140104; fax: +41 21 3140013.
E-mail address: etienne.pruvot@chuv.ch (E. Pruvot).
0167-5273/$ - see front matter © 2007 Elsevier Ireland Ltd. All rights reserved.
doi:10.1016/j.ijcard.2006.12.007true diagnostic performance of these dedicated facilities.
Moreover, patients with syncope often present with multiple
symptoms before and/or after the event. Syncope-related
symptoms have been traditionally used to separate vasovagal
from rhythmic causes [9–11] but predictive models of
syncope causes are still lacking.
In the present work we investigated a population of
patients referred to a syncope unit for unexplained syncope.
We sought first to evaluate the diagnostic yield of a stan-
dardized work-up, which turned out to correspond closely to
later published guidelines [12], and second, whether a certain
combination of clinical parameters based on history, ECG
and syncope-related symptoms were characteristics of either
rhythmic or reflex causes of syncope.
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2.1. Setting
This single center study was conducted in the syncope
clinic of the Service of Cardiology at the Lausanne University
hospital in Switzerland. On average, one patient is referred
daily to the clinic for the investigation of unexplained syn-
cope or presyncope. The study complies with the Declaration
of Helsinki, and has been approved by our local ethics
committee. Syncope was defined as a brief, self-limited loss
of consciousness with the inability to maintain postural tone.
Presyncope was defined as a near syncopal event. Patients
with symptoms compatible with other non syncopal condi-
tions such as seizure disorders, vertigo, dizziness or coma
were excluded.
2.2. Study design
Consecutive outpatients referred to our syncope clinic
were prospectively included between December 1st 1999 and
October 30th 2001. Patients underwent a standardized work-
up (Fig. 1) consisting of a history, physical examination
and 12-lead ECG analyzed by two of the investigators (E.P.
and E.G.). Patients underwent a 30-min head-up tilt test
(HUT) followed by upright and supine CSM in absence of
contra-indications [12], with continuous non invasive blood
pressure measurement (Finapres, Ohmeda). Drug challenges
with intravenous adenosine triphosphate [13] and sublingual
dinitrate isosorbide [14] were performed following a negative
baseline HUT and CSM. Hyperventilation testing was per-
formed only in patients with phobic, anxious and/or de-
pressive features. Evaluation by a psychiatrist was required in
all clinically suspect cases. Structural heart disease was ruled
out on the basis of history, physical examination and ECG
[12]. When the initial evaluation confirmed or suggested an
underlying cardiac disease, a stress test and an echocardio-
gram were usually performed. The latter was also performed
before any invasive study in patients not previously eval-Fig. 1. Standardized work-up.uated. Patients then re-integrated the common work-up.
Coronary angiography was performed when indicated. Elec-
trophysiological (EP) study was performed only in patients
with an underlying structural heart disease, or in those whose
non invasive work-up was negative but who required further
testing because of major trauma and/or for medico-legal
purposes. Importantly, a positive test was considered diag-
nostic when the test-induced symptom(s) matched the pre-
sentation of the clinical syncope, otherwise the test was
considered abnormal but non diagnostic.
2.3. Measurements
In order to maximize the reliability of data acquisition,
physicians in charge of the patients were trained to use a 600
items database (FileMaker Pro 5) specifically developed for
the management of syncope patients. The initial interview
focused on the number of syncopal episodes, precipitating
factors, occurrence and duration of prodromal and recovery
symptoms. The following 23 symptoms were systematical-
ly investigated: diaphoresis, nausea and/or vomiting, visual
changes, dyspnea, headache, chest pain, abdominal pain, pal-
pitations, vertigo, asthenia, incontinence, neurologic deficit,
impression of imminent death, diarrhea, sudation, tinnitus,
paresthesia, anxiety, tongue biting, difficulty to concentrate,
confusion, disorientation and tremor. Syncope-related trauma
was classified as: (1) major, defined as any fractures, head
injury or internal organ damage, or syncope resulting in a car
accident; or (2) minor, defined as any bruise, cut, or soft tissue
injury. The duration of the P-wave of the ECG was deter-
mined by averaging the P-wave value from three consecutive
beats, from at least two derivations (D2 and V1) [15]. Im-
portantly, P-wave duration was measured and reported in a
database before any investigations in order to avoid method-
ological bias.
2.4. Diagnostic criteria for causes of syncope
Diagnostic criteria for causes of syncope were established
before the study and adhered strictly to published data [12].
The diagnosis was assigned by one of the investigators (E.P.)
at the end of the standardized work-up which turned out to
follow the guidelines of the European Society of Cardiology
[12]. We did not establish final diagnoses on history alone or
as a part, but always using results of investigational tests.
Prodromes (i.e. history) were only used to establish that the
syncopal event taking place during a specific test did re-
produce the clinical event. However, the nature of prodromes
(i.e. nausea, diaphoresis, etc) in itself was not used to es-
tablish final diagnoses.
For statistical analysis, final causes of syncope were
grouped into 5 categories: (1) Rhythmic causes included
bradyarrhythmias (AV block and cardio-inhibitory carotid
sinus syndrome, CSS) and tachyarrhythmias (supra- and
ventricular tachycardia); (2) VV/Psy causes included vasova-
gal (VV, i.e. tilt induced) syncope and psychogenic pseudo-
Table 1
Baseline characteristics of the 317 patients
Age — years 53±201
Female 146 (46)
Hypertension 114 (35)
Hypercholesterolemia 90 (28)
Diabetes type 2 20 (6)
Active smoker 78 (25)
Coronary artery disease 54 (17)
Syncope frequency 6±171
Presyncope only 42 (13)
Time elapsed since first episode — years 5±81
Minor trauma 68 (21)
Major trauma 50 (16)
Hospitalization 198 (62)
1Mean±SD, unmarked data are n (%).
Table 2
Causes of syncope
n (%)
Neurally-mediated
Vasovagal (tilt-induced) 72 (23)
Situational 8 (3)
Vasodilatative CSS 14 (4)
Cardio-inhibitory CSS 56 (18)
Psychogenic pseudo-syncope 55 (17)
Orthostatic 10 (3)
Cardiac arrhythmias
Tachyarrhythmic 22 (7)
Ventricular tachycardia 11 (3)
Supraventricular tachycardia 11 (3)
AV block 7 (2)
Miscellaneous 5 (2)
Unexplained 68 (21)
Total 317 (100)
CSS: carotid sinus syndrome.
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hypotension and vasodilatative CSS; (4) Miscellaneous, and
(5) Undetermined when none of the above was applicable at
the end of the standardizedwork-up. The latter three categories
will be referred as Others in the sequel.
2.5. Statistical analysis
Analysis and construction of predictive models were
based on the first 317 consecutive patients included in the
study between December 1999 and October 2001. Validation
of the model was done on the next 65 consecutive patients
who met the inclusion criteria. For the construction of the
model a univariate screening of the different variables was
performed using Fisher's exact test to compare proportions of
any specific factor in the three main categories of syncope,
namely Rhythmic, VV/Psy or Others (see text for defini-
tions). Thus, in addition to age, sex, blood pressure and other
history parameters, 23 symptoms were tested and the sig-
nificance level was set at 0.001 to protect for the multiplicity
of tests (Bonferroni). Continuous variables were dichoto-
mized for simplicity and reproducibility, except age, which
was categorized in five (quintiles) or three (tertiles) in order to
assess whether age effect could be taken as linear. It turned
out that the quadratic component was not significant so that
the linear trend is adequate.
Significant factors (at 0.001) in this univariate screening
were then entered in a multivariable logistic regression and a
stepwise selection (step down) was used to build the model
(probability to remove 0.10). The overall significance of the
model is based on the Likelihood Ratio test. Two mod-
els were constructed, one which attempted to characterize
Rhythmic cases versus all Others, and another characterizing
VV/Psy cases versus all Others. These regression results were
then used to produce two so-called rules based on a simplified
reading of the results. Thus, using the combination of these
rules, patients could be classified as either probably
Rhythmic, probably VV/Psy, possibly both or neither. The
results of these rules have been confronted with the real data
in Table 6A (construction sample of 317) and 6B (validation
sample of 65).3. Results
3.1. Patient characteristics and causes of syncope
During the study period 317 consecutive patients were
enrolled. Table 1 reports the clinical characteristics of the
study group (mean age 53±20 y). The mean number of
syncopal episodes per patient was 6, with 13% of the patient
referred for presyncope only. Syncope resulted in a major
traumatic event in 16% and hospitalization in 62% of the
patients. Table 2 describes the spectrum of causes as di-
agnosed after our standardized work-up. Vasovagal (tilt-
induced) syncope was the most prevalent cause (23%),
followed by cardio-inhibitory CSS (18%). The prevalence of
psychogenic pseudo-syncope was surprisingly high (n=55,
17%), with panic disorders in 52 patients and conversion
disorder in 3 patients. Of these, half (n=25, 45%) manifested
spontaneously during HUT, while the remaining diagnoses
(n=30, 55%) were established during the hyperventilation
test. In both cases, the diagnosis was established because the
spontaneous or triggered response matched the clinical syn-
cope. Hypotensive disorders (orthostatic and vasodilatative
CSS) were diagnosed in 8% and tachyarrhythmic syncope in
7% of the patients. Other rare causes of syncope included
hypertrophic obstructive cardiomyopathy and neurological
causes (i.e. sub-clavian steal syndrome and seizure). Finally,
an implantable loop recorder (ILR, Reveal, Medtronic) was
proposed to 17 patients because of syncope-related compli-
cations; 13 patients were implanted and 4 refused the pro-
cedure. The device yielded a diagnosis in 6 (46%) patients
with an equal proportion of supraventricular tachycardia
(n=2), epilepsy (n=2) and hypotension (n=2). Interestingly,
both patients with supraventricular tachycardia had a
negative EP study, and the two patients diagnosed as epileptic
had a prior negative electroencephalogram. Adding the 1.8%
of diagnoses yielded by ILR incremented the overall
diagnosis rate of our standardized work-up from 79% to
81%. Of note, removing psychogenic causes which did not
Table 3
Diagnostic yield of current tests
n/N (%)
ECG 4/317 (1)
Orthostatic blood pressure test 15/295 (5)
Carotid sinus massage 38/264 (14)
Head-up tilt test 92/266 (35)
Hyperventilation test 61/78 (78)
Long term ECG recording 11/95 (12)
Echocardiogram 4/187 (2)
Exercise test 8/107 (7)
Electrophysiological study 15/61 (25)
Implantable loop recorder 6/13 (46)
N=number of tests performed; n=number of diagnostic tests.
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moderately the overall diagnostic yield of the work-up (72%).
3.2. Diagnostic yield of current tests
Table 3 reports the diagnostic yield of individual tests used
to establish syncope causes. CSM was performed in 264
patients, with 36% abnormal responses and 14% diagnostic
tests; nearly all (35/38) CSM were diagnostic in the upright
position while fewer than half (16/38) were positive supine.
HUT was performed in 266 patients with 36% abnormal
responses and 35% diagnostic tests. Of note, a psychogenic
pseudo-syncope was spontaneously observed during HUT in
an additional 22 patients. Hyperventilation testing was per-
formed in 78 patients: it reproduced the clinical event in the
22 patients with a spontaneous psychogenic manifestation
during HUT, and provided evidence for panic attacks as a
cause for syncope in an additional 39 patients, of which 9 alsoTable 4
Distribution of statistically⁎ significant parameters in final categories of syncope
Prodromes Rhythmic VV/Psy Hyp
N=85 N=127 N=2
n (%) n (%) n (%
Age — years 68±12 40±17 68±
P-wave duration — ms 115±15 101±12 117±
Number of prodromes 1±2 4±2 2±2
None 41 (48) 11 (9) 2 (8
Nausea/vomiting 8 (9) 47 (37) 1 (4
Diaphoresis 12 (14) 60 (47) 5 (2
Sudation 9 (11) 56 (44) 6 (2
Blurred vision 13 (15) 69 (54) 11 (4
Paresthesia 1 (1) 36 (28) 1 (4
Palpitations 4 (5) 38 (30) 0
Vertigo/dizziness 29 (34) 73 (57) 11 (4
Dyspnea 8 (9) 28 (22) 3 (1
Anxiety 2 (2) 25 (20) 1 (4
Asthenia/weakness 20 (24) 56 (44) 9 (3
Headache 0 21 (17) 2 (8
⁎pb0.001 in the comparison of Rhythm, VV/Psy and other three categories poole
Hypo: orthostatic hypotension and vasodilatative CSS; VV/Psy: vasovagal and psy
positive patients; Miscellaneous causes included situational; Rhythmic: bradyarrhy
and ventricular); Undetermined: syncope remaining unexplained after the standardhad another diagnosis. Thus, the overall diagnostic yield of
hyperventilation testing in patients with suggestive features at
history or spontaneous manifestation during HUT achieved
78%. The hyperventilation test triggered syncope or near
syncope in 13 (21%) of the 61 positive patients, and matched
prodromal symptoms (without syncope or near syncope) in
the remaining 48 (79%) patients. EP study was diagnostic in
25% of the 61 tested patients. Importantly, 74% of the final
causes of syncope were identified using non invasive testing,
while invasive testings (EP study and ILR) yielded an ad-
ditional 7% of diagnoses.
3.3. Predictive rules of Rhythmic and VV/Psy categories of
syncope
Logistic analysis identified 11 prodromes of the 23
screened symptoms as significantly related to categories (i.e.
Rhythmic and VV/Psy) of syncope. Table 4 reports the
distribution of the 11 significant prodromes in the 5 cate-
gories of syncope causes as defined in the Materials and
methods section. Interestingly, absence of prodromes (i.e.
sudden syncope) was much more prevalent in Rhythmic than
in the other defined causes. Conversely, nausea/vomiting,
diaphoresis, sudation, paresthesia and palpitations were
much more prevalent in VV/Psy causes than in any other
category, except for Miscellaneous which shared some
common features. Hypotensive causes showed no distinctive
pattern, while Undetermined causes shared some similarities
with Rhythmic causes with a high prevalence of sudden
onset.
Logistic regression identified age of the patients and
number of prodromes (among the 11 significant ones) as theo Miscellaneous Unexplained Total
4 N=13 N=68 N=317
) n (%) n (%) n (%)
16 60±16 56±18 53±20
18 108±13 109±15 108±16
2±1 1±2 3±2
) 0 37 (54) 91 (29)
) 3 (23) 8 (12) 67 (21)
1) 4 (31) 11 (16) 92 (29)
5) 4 (31) 10 (15) 85 (27)
6) 4 (31) 17 (25) 114 (36)
) 0 2 (3) 40 (13)
0 7 (10) 50 (16)
6) 7 (54) 13 (19) 133 (42)
3) 0 3 (4) 42 (13)
) 0 4 (6) 32 (10)
8) 4 (31) 11 (16) 100 (32)
) 1 (8) 2 (3) 26 (8)
d.
chogenic syncope; N: number of patients in each category; n: number (%) of
thmias (AV block and cardio-inhibitory CSS) and tachyarrhythmias (supra-
ized work-up.
Table 5A
Results of the multivariable logistic regression: model for Rhythmic syncope
Logit
estimates
Number of observations =317
Likelihood ratio test pb0.00001
Rhythmic Coefficients Standard error WaldP 95% CI
AgeCat 1.142 0.208 b0.0005 0.734 1.550
ProdCat −1.330 0.342 b0.0005 −2.002 −0.659
Constant −3.068 0.537 b0.0005 −4.120 −2.015
AgeCat and ProdCat are defined in the text and repeated in Table 5C. WaldP
is the individual significance of each factor; CI: confidence interval.
Coefficients onAgeCat and ProdCat suggest opposite effects for these factors
(similar size but opposite sign); the resulting rule is shown in Table 5C.
Table 5C
Predictive rules of Rhythmic and VV/Psy syncope
Predictive factors Rules Cut-off values
Rhythmic ⋅ Number of
prodromes
AgeCat−ProdCat−2 ≥0=Rhythmic
⋅ Age b0=Not Rhythmic
VV/Psy ⋅ Number of
prodromes
2×ProdCat−P-
waveCat−AgeCat+2
≥0=VV/Psy
⋅ Age b0=Not VV/Psy
⋅ P-wave duration
AgeCat scores 1 for age ≤45 y; 2 for age 45bXb65 y and 3 for age N65 y;
ProdCat scores: 0 for ≤1 symptom, 1 for ≥2 symptoms; P-waveCat scores:
0 for P-wave b120 ms, 1 for P-wave ≥120 ms or non sinus rhythm.
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The same two factors, in addition to the “ECG P-wave
duration”, were also predictive of VV/Psy causes. For the
logistic regression, age was categorized (AgeCat) into three
classes scored: 1 for age (≤45 y; 2 for age 45bXb65 y and 3
for age N65 y; similarly, prodromes were categorized into 2
classes (ProdCat) scored 0 for ≤1 symptom, and 1 for ≥2
symptoms. Finally the ECG P-wave duration was separated
(P-waveCat) into two classes scored 0 for duration b120 ms
and 1 for duration ≥120 ms or non sinus rhythm (i.e. atrial
fibrillation and flutter). AgeCat and ProdCat were optimally
combined in a predictive model of Rhythmic syncope as
follows: Rhythmic score=AgeCat−ProdCat−2; a score ≥0
classified patients as suffering from Rhythmic syncope, and
a score b0 as non Rhythmic syncope. Similarly, AgeCat,
ProdCat and P-waveCat were optimally combined in a pre-
dictive model of VV/Psy syncope using the following: VV/
Psy score=2×ProdCat−AgeCat−P-waveCat+2; a score
≥0 classified patients as suffering from VV/Psy syncope,
and a score b0 as non VV/Psy syncope. Tables 5A, 5B
and 5C summarize predictive factors, rules and cut-off
values for both Rhythmic and VV/Psy predictive models.
For example a 40y old patient with syncope preceded by
diaphoresis and sudation, and a normal P-wave duration
(b120 ms) has a Rhythmic score of 0 (1−1−2=−2), which
classifies the patient as not Rhythmic, and a VV/Psy score of
1 (2×1−0−1+2=3) which classifies the patient as VV/Psy.
Table 6A shows the joint classification using Rhyth-
mic and VV/Psy models together. Forty nine percent of theTable 5B
Results of the multivariable logistic regression: model for VV/Psy syncope
Logit estimates Number of observations =297
Likelihood ratio test pb0.00001
VV/Psy Coefficients Standard error WaldP 95% CI
AgeCat −1.194 0.223 b0.0005 −1.630 −0.758
ProdCat 1.960 0.312 b0.0005 1.349 2.572
P-waveCat −0.880 0.376 0.019 −1.616 −0.143
Constant 1.142 0.445 b0.0005 0.271 2.014
The coefficient on ProdCat is roughly twice that of AgeCat and P-waveCat
but with opposite sign; the resulting rule is shown in Table 5C. Only 297
patients had P-wave measurements; missing P-waves (i.e. AF) were assumed
to have duration ≥120 m.patients classified as Rhythmic were true Rhythmic with
only 7% of true VV/Psy; 72% of the patients classified as
VV/Psy were true VV/Psy with only 5% of true Rhythmic.
Importantly, none of the patients remained unclassified.
Finally 58 (18%) patients were classified as both Rhythmic
and VV/Psy, of which 41% were true Rhythmic and 21%
were true VV/Psy. These patients were ultimately considered
as Rhythmic. Both predictive rules were then evaluated on
the study population in a two-step classification model, and
results were compared with final causes of syncope as given
by the standardized work-up. Applying the Rhythmic model
classified 166/317 (52%) patients as Rhythmic with a sen-
sitivity of 91% (77/85), a specificity of 62% (143/232), a
positive predictive value (PPV) of 46% and a negative
predictive value (NPV) of 95%. Applying the VV/Psy model
classified all remaining patients as VV/Psy with an overall
sensitivity of 85% (108/127), specificity of 77% (147/190),
PPVof 72% and NPVof 89%. Predictive model for the other
syncope causes were not developed because of the limited
number of patients.
3.4. Validation of the two rules
The performance of the joint classification using both
Rhythmic and VV/Psy models was then evaluated on a
validation population of 65 newly included patients referred
to the clinic. Applying the Rhythmic model classified 24/65
(37%) patients as Rhythmic with a sensitivity of 59% (10/
17), a specificity of 71% (34/48), a PPVof 42% and a NPVofTable 6A
Classification based on the combination of Rhythmic and VV/Psy models in
the derivation sample (n=317)
Rhythmic rule
b0=Not Rhythmic ≥0=Rhythmic
VV/Psy rule b0=Not VV/Psy, n 0 108
True Rhythmic, % 0 49
True VV/Psy, % 0 7
True Others, % 100 44
≥0=VV/Psy, n 151 58
True Rhythmic, % 5 41
True VV/Psy, % 72 21
True Others, % 23 38
Table 6B
Classification based on the combination of Rhythmic and VV/Psy models in
the validation sample (n=65)
Rhythmic rule
b0=Not Rhythmic ≥0=Rhythmic
VV/Psy rule b0=Not VV/Psy, n 0 9
True Rhythmic, % 0 66
True VV/Psy, % 0 0
True Others, % 100 34
≥0=VV/Psy, n 41 15
True Rhythmic, % 17 26
True VV/Psy, % 51 26
True Others, % 32 48
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patients as VV/Psy with an overall sensitivity of 84% (21/
25), specificity of 50% (20/40), PPV of 51% and NPV of
83% (Table 6B).
3.5. Meaning of P-wave duration
We assessed the value of the P-wave duration according to
the categories of syncope. Interestingly, 14% (14/97) of the
patients with prolonged P-wave duration were VV/Psy
syncope while 42% (41/97) were Rhythmic syncope. In
these 97 patients, the proportion of hypertension (53%),
ischemic heart disease (25%) and NYHA class II (41%) was
high, with 70% having at least one of these clinical char-
acteristics. In the 85 patients with Rhythmic syncope, the
prevalence of hypertension (48%), ischemic heart disease
(27%) and NYHA class II (45%) was also high, as opposed to
12%, 5% and 10% respectively in the 127 patients with VV/
Psy syncope.
4. Discussion
4.1. Diagnostic yield of a standardized work-up
The diagnostic approach of patients with syncope is a
difficult and challenging clinical problem. Despite multiple
investigations, syncope remains unexplained in 13–54% of
the cases [1–6]. Diagnostic performance, however, varied
widely between studies carried out with [1,2,6,8,16,17]
or without [3,5,8] standardized work-up, in unselected
[1,5,6,16–18] or referred [3,19] patients. Early studies
[9,20,21] reported 50–63% of diagnoses in unselected
patients; however, most of the causes were determined
on the basis of clinical history and physical examination.
Importantly, the superiority of standardized investigation
strategies over usual practice has been recently shown in
patients with syncope addressed to emergency departments
[1,6–8,16–18]. Furthermore, the availability of syncope
clinics has dramatically changed the daily practice of syn-
cope by re-orienting patients toward functional tests such
as HUT and CSM. The present study shows that a standard-
ized work-up yielded an etiology in more than 75% of thepatients, and that most causes were diagnosed non inva-
sively combining HUT, CSM and hyperventilation testing.
Importantly, syncope etiologies requiring invasive diagnos-
tic procedures (i.e. tachyarrhythmias) remained rare and
occurred in less than 7% of our population. Thus, similarly
to Farwell et al. [17], the present study stresses the utility of
a standardized work-up focusing on non invasive testing for
the investigation of unexplained recurrent syncope referred
to a syncope clinic.
4.2. Distribution of syncope causes in a syncope clinic
In the present study, the distribution of syncope causes
is well in accordance with the published literature
[11,16,17,21,22]. Vasovagal (tilt-induced) was the most
prevalent (23%), followed by cardio-inhibitory CSS (18%),
hypotensive (8%) and tachyarrhythmic (7%) syncope. Al-
though the lack of gold standard remains a well known
limiting factor for studies focusing on syncope, we paid
careful attention to match final diagnoses with the clinical
syncope. For instance, patients with typical tilt-induced
vasovagal syncope but who complained of sudden syncope
were not considered as vasovagal.
Psychogenic causes of syncope have been originally
considered as negligible, accounting for less than 6% of
etiologies [6,16,20]. Some studies [23–25], however, suggest
that the prevalence of psychogenic pseudo-syncope may be
as high as 26% in an unexplained syncope population. Im-
portantly, Linzer et al. have shown the relationship between
syncope and both panic and depression disorders [23,24]; the
recurrence rate dropped from 50% in untreated patients to
10% in those undergoing a psychotherapy. The high prev-
alence of psychogenic pseudo-syncope (17%) in the present
study is at variance with recent studies performed in a similar
set-up (syncope clinic) [8,26]. Our patients were systemat-
ically screened for anxiety, phobic and depressive features.
Only those with positive feature(s) were tested at the end of
our standardized work-up. Panic and conversion disorders
were the most prevalent diagnoses. Panic disorders were
diagnosed during hyperventilation testing (53%) or sponta-
neous spells (42%), while conversion disorders (5%) always
manifested spontaneously during HUT. During hyperventi-
lation testing, only patients with symptoms strictly matching
the clinical event were diagnosed as suffering from panic
attacks. Moreover, other organic and reflexogenic causes of
syncope had been previously excluded as part of our stan-
dardized work-up but a vasovagal event may still have oc-
curred [27]. Interestingly, patients with psychogenic pseudo-
syncope were young (40 y), with two thirds of female gender,
and suffered more frequently of presyncope (22%) than other
better accepted causes such as vasovagal (13%) or rhythmic
(8%) syncope. Removing psychogenic diagnoses without
spontaneous manifestation from final causes still left 8% of
our outpatient population with a non disputable diagnosis
of psychogenic pseudo-syncope. In summary, the present
findings suggest that panic, depressive and phobic features
255D. Graf et al. / International Journal of Cardiology 123 (2008) 249–256should be checked routinely in the evaluation of patients with
unexplained syncope. Although a link between anxiety and
vasovagal syncope has been suggested [28], further studies
are needed to elucidate the pathophysiologic mechanisms
leading to syncope.
Twenty one percent of the patients remained with un-
explained syncope after our standardized work-up. Interest-
ingly, these patients shared some features with Rhythmic
patients (46% of sudden onset). An implantable loop recorder
(Reveal, Medtronic) was proposed to 17 of these patients
because of syncope-related complications; 13 patients were
implanted and 4 refused the procedure. The device yielded a
diagnosis in 6/13 (46%) patients with an equal proportion of
supraventricular tachycardia (n=2), epilepsy (n=2) and hy-
potension (n=2). The present results confirm the incremental
benefit of implantable loop recorder in patients with unex-
plained syncope after a negative standardized work-up [29].
4.3. Predictive rules of Rhythmic and VV/Psy causes of
syncope
Some studies have evaluated the ability of clinical features
to predict syncope causes [10,11,26,30,31]. Martin et al.
reported that the duration of prodromal symptoms was longer
for neurally-mediated than for cardiac syncope [11]. Calkins
et al. reported that AV block and ventricular tachycardia
frequently manifested as sudden syncope whereas vasovagal
events were usually preceded by prodromal symptoms [10].
In contrast, Alboni et al. found that symptoms and signs
considered suggestive of vasovagal syncope were equally
distributed in both cardiac and neurally-mediated causes [26].
Recently, Sheldon et al. successfully predicted vasovagal
causes using a simple point score in a syncope population
recruited from primary hospitals and referral units [31]. Our
findings extend some of their observations regarding the
prevalence of symptoms and heart disease. Patients with non
rhythmic syncope (vasovagal or psychogenic) reported mul-
tiple symptoms before the events, were younger and had little
functional limitation and structural heart disease as compared
to patients with brady- or tachyarrhythmic causes. Another
intriguing finding of this analysis is that patients with vaso-
vagal and psychogenic pseudo-syncope appeared to share
many prodromal symptoms. Interestingly, Carey et al. have
recently observed some hyperventilation-induced hypocap-
nia in the minutes preceding the onset of vasovagal syncope
during head-up tilt test [32]. It is believed that hypocapnia is
part of a counterregulation process to increase venous tone
and preload before syncope, which might explain some of the
common clinical features between vasovagal and psycho-
genic pseudo-syncope [32]. Alternatively, it may be that
some patients classified as psychogenic are indeed suffering
from vasovagal syncope.
In the present study, the positive predictive value of
Rhythmic and VV/Psy models was modest, while both
negative predictive values were high, which might be of
clinical interest. Only the P-wave duration but no other ECGparameter (e.g. QRS and QT duration, Q wave, etc.) was
identified by multivariable analysis as a predictor of syncope
causes. Patients with prolonged P-wave duration were more
likely to suffer from Rhythmic syncope including tachy- and
bradyarrhythmias. Prolonged P-wave duration is a consistent
finding in patients with sinus node disease [33] or ventricular
arrhythmias, and could reflect some degree of electrome-
chanical remodeling. In several studies, prolonged P-wave
duration was shown to be a characteristic of patients with
paroxysmal AF, and to be predictive of AF recurrence and
failure to maintain sinus rhythm [34]. In addition, patients
at very early stages of hypertension have demonstrable evi-
dence of prolonged atrial conduction by P-wave signal-aver-
aged ECG; also P-wave duration increased with severity of
hypertension [35]. Interestingly, in patients with Rhythmic
syncope P-wave duration (115±15ms) was prolonged as
compared to patients with VV/Psy syncope (101±12ms). In
patients with Rhythmic syncope, the prevalence of hyper-
tension, ischemic heart disease and congestive heart fail-
ure was higher than in patients with VV/Psy syncope. Thus
prolonged P-wave duration identifies a subgroup of patients
more likely to suffer from cardiovascular disorders and
Rhythmic syncope.
4.4. Limitations
Our study bears some limitations. First, the present
findings are hardly applicable at primary care emergency
departments because patients were referred from a wide
geographical area. Second, in the absence of a gold standard
some uncertainty remains about the attribution of syncope
causes, which is particularly true for psychogenic pseudo-
syncope. Attribution of a diagnosis, however, relied on the
matching of patients' clinical event(s) by results of inves-
tigational tests, and followed strict diagnostic criteria [12].
Third, whether the standardization of syncopemanagement is
cost- and recurrence rate effective has not been addressed in
the present study. Some recent studies using a similar set-up,
however, suggested so [36,37].
In conclusion, the main findings of our study are that:
(1) a standardized work-up yields more than three quarters
of causes in patients referred to a syncope clinic for unex-
plained syncope, most causes being diagnosed using non
invasive tests; (2) vasovagal (tilt-induced) syncope and
psychogenic pseudo-syncope represents more than two
third of all causes, while brady- and tachyarrhythmic syn-
cope occurs in 25% of the patients; (3) rhythmic, vasovagal
and psychogenic causes of syncope can reasonably be pre-
dicted using simple models based on clinical history, age
and P-wave duration.
Acknowledgements
This work was supported by the Fondation Vaudoise de
Cardiologie and by the Fondation Suisse de Bourses en
Médecine et Biologie.
256 D. Graf et al. / International Journal of Cardiology 123 (2008) 249–256References
[1] Sarasin FP, Louis-Simonet M, Carballo D, et al. Prospective evaluation
of patientswith syncope: a population-based study. Am JMed 2001;111
(3):177–84.
[2] Ammirati F, Colivicchi F, Santini M. Diagnosing syncope in clinical
practice. Implementation of a simplified diagnostic algorithm in a
multicentre prospective trial — the OESIL 2 study (Osservatorio
Epidemiologico della Sincope nel Lazio). Eur Heart J 2000;21
(11):935–40.
[3] Croci F, Brignole M, Alboni P, et al. The application of a standardized
strategy of evaluation in patients with syncope referred to three
syncope units. Europace 2002;4(4):351–5.
[4] Ammirati F, Colivicchi F, Minardi G, et al. The management of
syncope in the hospital: the OESIL Study (Osservatorio Epidemiolo-
gico della Sincope nel Lazio). G Ital Cardiol 1999;29(5):533–9.
[5] Blanc JJ, L'Her C, Touiza A, Garo B, L'Her E, Mansourati J.
Prospective evaluation and outcome of patients admitted for syncope
over a 1 year period. Eur Heart J 2002;23(10):815–20.
[6] Farwell DJ, Sulke AN. Does the use of a syncope diagnostic protocol
improve the investigation and management of syncope? Heart 2004;90
(1):52–8.
[7] Colivicchi F, Ammirati F, Melina D, Guido V, Imperoli G, Santini M.
Development and prospective validation of a risk stratification system
for patients with syncope in the emergency department: the OESIL risk
score. Eur Heart J 2003;24(9):811–9.
[8] Brignole M, Disertori M, Menozzi C, et al. Management of syncope
referred urgently to general hospitals with and without syncope units.
Europace 2003;5(3):293–8.
[9] Wayne HH. Syncope. Physiological considerations and an analysis of
the clinical characteristics in 510 patients. Am J Med 1961;30:418–38.
[10] Calkins H, Shyr Y, Frumin H, Schork A, Morady F. The value of the
clinical history in the differentiation of syncope due to ventricular
tachycardia, atrioventricular block, and neurocardiogenic syncope. Am
J Med 1995;98(4):365–73.
[11] Martin GJ, Adams SL, Martin HG, Mathews J, Zull D, Scanlon PJ.
Prospective evaluation of syncope. Ann Emerg Med 1984;13
(7):499–504.
[12] Brignole M, Alboni P, Benditt D, et al. Task force on syncope,
European Society of Cardiology. Part 1. The initial evaluation of
patients with syncope. Europace 2001;3(4):253–60.
[13] Mittal S, Stein KM, Markowitz SM, Slotwiner DJ, Rohatgi S, Lerman
BB. Induction of neurally mediated syncope with adenosine.
Circulation 1999;99:1318–24.
[14] Ammirati F, Colivicchi F, Biffi A, Magris B, Pandozi C, Santini M.
Head-up tilt testing potentiated with low-dose sublingual isosorbide
dinitrate: a simplified time-saving approach for the evaluation of
unexplained syncope. Am Heart J 1998;135(4):671–6.
[15] Michelucci A, Bagliani G, Colella A, et al. P wave assessment: state of
the art update. Card Electrophysiol Rev 2002;6(3):215–20.
[16] Brignole M, Menozzi C, Bartoletti A, et al. A new management of
syncope: prospective systematic guideline-based evaluation of patients
referred urgently to general hospitals. Eur Heart J 2006;27(1):76–82.
[17] Farwell DJ, Sulke AN. A randomised prospective comparison of three
protocols for head-up tilt test and carotid sinus massage. Int J Cardiol
2005;105(3):241–9.
[18] Sarasin FP, Carballo D, Slama S, Louis-Simonet M. Usefulness of
24-h Holter monitoring in patients with unexplained syncope and a
high likelihood of arrhythmias. Int J Cardiol 2005;101(2):203–7.[19] Sagrista-Sauleda J, Romero-Ferrer B, Moya A, Permanyer-Miralda G,
Soler-Soler J. Variations in diagnostic yield of head-up tilt test and
electrophysiology in groups of patients with syncope of unknown
origin. Eur Heart J 2001;22(10):857–65.
[20] KapoorWN, Karpf M,Wieand S, Peterson JR, Levey GS. A prospective
evaluation and follow-up of patients with syncope. N Engl J Med
1983;309:197–204.
[21] Silverstein MD, Singer DE, Mulley AG, Thibault GE, Barnett GO.
Patients with syncope admitted to medical intensive care units. JAMA
1982;248:1185–9.
[22] Oh JH, Hanusa BH, Kapoor WN. Do symptoms predict cardiac
arrhythmias and mortality in patients with syncope? Arch Int Med
1999;159:375–80.
[23] Linzer M, Felder A, Hackel A, et al. Psychiatric syncope: a new look at
an old disease. Psychosomatics 1990;31:181–8.
[24] Linzer M, Varia I, Pontinen M, Divine GW, Grubb BP, Estes III NA.
Medically unexplained syncope: relationship to psychiatric illness. Am
J Med 1992;92(1A):18S–25S.
[25] Kouakam C, Lacroix D, Klug D, Baux P, Marquie C, Kacet S.
Prevalence and prognostic significance of psychiatric disorders in
patients evaluated for recurrent unexplained syncope. Am J Cardiol
2002;89(5):530–5.
[26] Alboni P, Brignole M, Menozzi C, et al. Diagnostic value of history in
patients with syncope with or without heart disease. J Am Coll Cardiol
2001;37(7):1921–8.
[27] Moya A, Brignole M, Menozzi C, et al. Mechanism of syncope in
patients with isolated syncope and in patients with tilt-positive
syncope. Circulation 2001;104(11):1261–7.
[28] Engel GL. Psychologic stress, vasodepressor (vasovagal) syncope, and
sudden death. Ann Intern Med 1978;89:403–12.
[29] Brignole M, Menozzi C, Moya A, et al. Mechanism of syncope in
patients with bundle branch block and negative electrophysiological
test. Circulation 2001;104(17):2045–50.
[30] Alboni P, Brignole M, Menozzi C, et al. Clinical spectrum of neurally
mediated reflex syncopes. Europace 2004;6(1):55–62.
[31] Sheldon R, Rose S, Connolly S, Ritchie D, Koshman ML, Frenneaux
M. Diagnostic criteria for vasovagal syncope based on a quantitative
history. Eur Heart J 2006;27(3):344–50.
[32] Carey BJ, Eames PJ, Panerai RB, Potter JF. Carbon dioxide, critical
closing pressure and cerebral haemodynamics prior to vasovagal
syncope in humans. Clin Sci (Lond) 2001;101(4):351–8.
[33] Sanders P, Morton JB, Kistler PM, et al. Electrophysiological and
electroanatomic characterization of the atria in sinus node disease:
evidence of diffuse atrial remodeling. Circulation 2004;109(12):1514–22.
[34] Aytemir K, Aksoyek S, Yildirir A, Ozer N, Oto A. Prediction of atrial
fibrillation recurrence after cardioversion by P wave signal-averaged
electrocardiography. Int J Cardiol 1999;70(1):15–21.
[35] Madu EC, Baugh DS, Gbadebo TD, Dhala A, Cardoso S. Effect of
ethnicity and hypertension on atrial conduction: evaluation with high-
resolution P-wave signal averaging. Clin Cardiol 2001;24(9):597–602.
[36] Kenny RA, O'Shea D,Walker HF. Impact of a dedicated syncope and falls
facility for older adults on emergency beds.AgeAgeing 2002;31(4):272–5.
[37] Shen WK, Decker WW, Smars PA, et al. Syncope Evaluation in the
Emergency Department Study (SEEDS): a multidisciplinary approach
to syncope management. Circulation 2004;110(24):3636–45.
